Bengaluru: A collaboration between Biotechnology Research and Innovation Council's Institute for Stem Cell ... and CMC Vellore has resulted in the country's first human gene therapy trial for ...

Prime Medicine’s modular editing tech may lower off-target risk, but key data and funding milestones remain ahead. Find out ...

The hope is that the gene therapy could provide the first alternative to allogeneic haematological stem cell transplantation ... and controls (CMC) data. The company also has two phase 2 trials ...

Flow cytometers. Genomics. Particle counters/analyzers ... supporting applications such as UCAR-T cell therapy. For gene therapy, we offer MaxNuclease to eliminate contaminants like host DNA and ...

Joe DePinto, MBA, head of cell, gene and advanced therapies at McKesson , met with MHE at the annual Asembia Specialty ...

Fran Gregory, PharmD, MBA, VP of emerging therapies at Cardinal Health, talks about the importance of market access strategies in the cell and gene therapy space.

As the number of cell and gene therapies expands, it's increasingly important for long-term patient data, explained Fran ...

Many diseases are caused by a missing or defective copy of a single gene. For decades, scientists have been working on gene ...